Endocrine Gland Neoplasms  >>  Imlygic (talimogene laherparepvec)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Imlygic (talimogene laherparepvec) / Amgen
NCT00402025: Talimogene Laherparepvec in Patients With Unresectable Pancreatic Cancer

Completed
1
17
US
Talimogene Laherparepvec, OncoVEX^GM-CSF, T-VEC, IMLYGIC
BioVex Limited
Pancreatic Cancer
01/08
01/08

Download Options